Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 3/20 | 0.61 |
| ▸ | PPARA | Q07869 | 3/20 | 0.61 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.61 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.61 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.61 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.61 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.60 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.60 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.57 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.56 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10534527 | 1.00 | PPARG (0.61) | PPARGPPARACHRM2CHRM1CHRM3 | |
| SCHEMBL17509808 | 1.00 | PPARG (0.61) | PPARGPPARACHRM2CHRM1CHRM3 | |
| SCHEMBL8956379 | 1.00 | PPARG (0.61) | PPARGPPARACHRM2CHRM1CHRM3 | |
| SCHEMBL9747684 | 1.00 | PPARG (0.61) | PPARGPPARACHRM2CHRM1CHRM3 | |
| SCHEMBL9796229 | 1.00 | PPARG (0.61) | PPARGPPARACHRM2CHRM1CHRM3 | |
| SCHEMBL3297777 | 1.00 | PPARG (0.61) | PPARGPPARACHRM2CHRM1CHRM3 | |
| SCHEMBL4817193 | 0.98 | CHRM2 (0.63) | PPARGPPARACHRM2CHRM1CHRM3 | |
| SCHEMBL145383 | 0.93 | CHRM2 (0.65) | CHRM2CHRM1CHRM3TAAR1HDAC1 | |
| SCHEMBL21002124 | 0.93 | TAAR1 (0.69) | CHRM2CHRM1CHRM3TAAR1HDAC1 | |
| SCHEMBL21381118 | 0.91 | PPARA (0.68) | PPARGPPARACHRM2CHRM1CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140357891-A1 | PROCESS FOR PREPARING A CROSS LINKING CATALYST FROM CASHEW NUT SHELL LIQUID | COUNCIL SCIENT IND RES (IN) | 2014-12-04 | — | — | US | claimed |
| EP-2788319-A1 | PROCESS FOR PREPARING A CROSS LINKING CATALYST FROM CASHEW NUT SHELL LIQUID | Council of Scientific & Industrial Research (IN) | 2014-10-15 | — | — | EP | claimed |
| WO-2013084248-A1 | PROCESS FOR PREPARING A CROSS LINKING CATALYST FROM CASHEW NUT SHELL LIQUID | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2013-06-13 | — | — | WO | claimed |
| US-7312337-B2 | Oxadiazoles and their manufacture | EASTMAN KODAK COMPANY (US) | 2007-12-25 | — | — | US | claimed |
| US-7268235-B2 | Method for preparation of N-pyrazolylamidoximes | EASTMAN KODAK COMPANY (US) | 2007-09-11 | — | — | US | claimed |
| US-20060074245-A1 | Method for preparation of N-pyrazolylamidoximes | EASTMAN KODAK COMPANY | 2006-04-06 | — | — | US | claimed |
| US-20060069262-A1 | Oxadiazoles and their manufacture | EASTMAN KODAK COMPANY | 2006-03-30 | — | — | US | claimed |
| CN-115260448-A | Bio-based diisocyanate, preparation method thereof and polyurethane elastomer | Evoco有限公司 | 2022-11-01 | — | — | CN | disclosed |
| US-11161917-B2 | Method for producing cellulose derivative, and cellulose derivative | NEC CORPORATION (JP) | 2021-11-02 | — | — | US | disclosed |
| US-20190048099-A1 | METHOD FOR PRODUCING CELLULOSE DERIVATIVE, AND CELLULOSE DERIVATIVE | NEC CORPORATION (JP) | 2019-02-14 | — | — | US | disclosed |
| EP-2788319-B1 | PROCESS FOR PREPARING A CROSS LINKING CATALYST FROM CASHEW NUT SHELL LIQUID | COUNCIL SCIENT IND RES (IN) | 2018-03-07 | — | — | EP | disclosed |
| US-20160254070-A1 | HYBRID PANI/CARBON NANO-COMPOSITES FOR PRODUCTION OF THIN, TRANSPARENT AND CONDUCTIVE FILMS | TECHNION RESEARCH AND DEVELOPMENT FOUNDATION, LTD. (IL) | 2016-09-01 | — | — | US | disclosed |
| US-20160200836-A1 | METHOD FOR PRODUCING CELLULOSE DERIVATIVE, AND CELLULOSE DERIVATIVE | NEC CORPORATION (JP) | 2016-07-14 | — | — | US | disclosed |
| US-20050038274-A1 | Antistatic and antidust agents, compositions thereof, and methods of manufacture | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2005-02-17 | — | — | US | disclosed |
| US-20050038275-A1 | Antistatic and antidust agents, compositions thereof, and methods of manufacture | CITIBANK, N.A., AS COLLATERAL AGENT | 2005-02-17 | — | — | US | disclosed |
| US-6841598-B2 | Antistatic and antidust agents, compositions thereof, and methods of manufacture | GENERAL ELECTRIC COMPANY (US) | 2005-01-11 | — | — | US | disclosed |
| WO-2004016683-A1 | ANTISTATIC AND ANTIDUST AGENTS, COMPOSITIONS THEREOF, AND METHODS OF MANUFACTURE | GENERAL ELECTRIC COMPANY (US) | 2004-02-26 | — | — | WO | disclosed |
| US-20040034131-A1 | Antistatic and antidust agents, compositions thereof, and methods of manufacture | GENERAL ELECTRIC COMPANY (US) | 2004-02-19 | — | — | US | disclosed |
| US-6552107-B1 | For use in electrostatic dissipation to electrochromic displays such as use in antistatic ESD coatings, absorption of radar frequencies, corrosion prevention, EMI/RFI shielding, electrochemical actuators, lithographic resists lightning | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2003-04-22 | — | — | US | disclosed |
| US-4888268-A | DEVELOPING IN PRESENCE OF AMINE | FUJI PHOTO FILM CO., LTD. (JP) | 1989-12-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050038275-A1 | Antistatic and antidust agents, compositions thereof, and methods of manufacture | POLL, SIGMAR1, H1-0 | PPARG 1936/4885PPARA 997/4885CHRM2 227/4885 |
| US-20050038274-A1 | Antistatic and antidust agents, compositions thereof, and methods of manufacture | POLL, SIGMAR1, H1-0 | PPARG 1936/4885PPARA 997/4885CHRM2 227/4885 |
| US-20140357891-A1 | PROCESS FOR PREPARING A CROSS LINKING CATALYST FROM CASHEW NUT SHELL LIQUID | ACSL3, NAPEPLD, NANS | PPARG 1862/4885PPARA 1107/4885CHRM2 1540/4885 |
| US-20060069262-A1 | Oxadiazoles and their manufacture | OXA1L, CYP1B1, OXER1 | PPARG 3218/4885PPARA 3440/4885CHRM2 2878/4885 |
| US-20060074245-A1 | Method for preparation of N-pyrazolylamidoximes | KCNH1, KCNJ2, KCNH2 | PPARG 2323/4885PPARA 3200/4885CHRM2 145/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.